The information regarding certain legal proceedings in which we are involved as set forth in Note 14 – Commitments and Contingencies of the Notes to the Condensed Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report on Form 10-Q) is incorporated by reference into this Item 1.
In addition, we are involved in various other legal proceedings arising in the normal course of our businesses.
At this time, we do not believe any material losses under these claims to be probable.
Item 1A.
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A.
“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018.
Item 2.
Information is based on trade dates of repurchase transactions.
Share repurchases were made pursuant to our Common Stock Repurchase Program authorized by our Board of Directors on August 8, 2019.
The program allows for the purchase of up to $500 million of outstanding common stock in one or more transactions on the open market or in privately negotiated purchases.
The exhibits listed in the Exhibit Index immediately preceding such exhibits are filed as part of this Report.
Filed herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
